API nitrosamines: method sensitivity issues
European Pharmaceutical Review
AUGUST 22, 2022
1 This has led to a great deal of pre-competitive data sharing. As the data is anonymised it will not be possible to select excipient suppliers based on lowest available nitrite levels, but it may prompt some suppliers to publish this information as it could provide a competitive advantage. 2022 [cited 30 July 2022]. Assessment report.
Let's personalize your content